Peter Brown

Stock price provided by Lang & Schwarz

Showing transactions by Peter Brown in Corcept Therapeutics Incorporated.

Quarter	Type	Shares before	Shares after	Change	Price range
2025-Q1	Sell	6.2M	6.1M	-56K	€48.33–€70.55
2024-Q4	Sell	6.5M	6.2M	-310K	€38.96–€58.68
2024-Q3	Sell	6.9M	6.5M	-404K	€27.77–€42.06
2024-Q2	Sell	7.1M	6.9M	-206K	€20.69–€32.00
2024-Q1	Buy	6.7M	7.1M	+393K	€19.40–€24.80
2023-Q4	Buy	6.6M	6.7M	+111K	€22.80–€29.80
2023-Q3	Sell	6.7M	6.6M	-85K	€19.90–€31.60
2023-Q2	Sell	6.8M	6.7M	-88K	€19.50–€23.20
2023-Q1	Sell	7.3M	6.8M	-501K	€17.88–€22.48
2022-Q4	Buy	7.2M	7.3M	+91K	€18.34–€29.77
2022-Q3	Sell	7.8M	7.2M	-636K	€24.40–€28.77
2022-Q2	Buy	7.8M	7.8M	+63K	€16.42–€23.74
2022-Q1	Sell	8M	7.8M	-253K	€15.10–€22.60
2021-Q4	Sell	8.2M	8M	-224K	€15.00–€20.60
2021-Q3	Sell	8.5M	8.2M	-274K	€16.60–€18.90
2021-Q2	Sell	8.8M	8.5M	-252K	€16.50–€20.40
2021-Q1	Sell	9.3M	8.8M	-568K	€19.50–€25.00
2020-Q4	Sell	9.6M	9.3M	-265K	€14.10–€22.00
2020-Q3	Buy	8.9M	9.6M	+686K	€10.20–€16.80
2020-Q2	Buy	8.3M	8.9M	+617K	€10.10–€16.20
2020-Q1	Buy	7.8M	8.3M	+535K	€9.05–€12.90
2019-Q4	Buy	6.5M	7.8M	+1.2M	€10.90–€15.40
2019-Q3	Buy	5.6M	6.5M	+934K	€9.10–€13.30
2019-Q2	Buy	5.1M	5.6M	+533K	€8.64–€11.23
2019-Q1	Buy	4.6M	5.1M	+411K	€8.65–€13.83
2018-Q4	Buy	4.4M	4.6M	+232K	€9.90–€15.85
2018-Q3	Sell	4.8M	4.4M	-383K	€10.22–€13.21
2018-Q1	Sell	5M	4.8M	-156K	€11.70–€21.00
2017-Q4	Buy	3.7M	5M	+1.3M	€13.19–€17.52
2017-Q3	Buy	2.7M	3.7M	+986K	€10.15–€16.41
2017-Q2	Buy	1.9M	2.7M	+825K	€8.27–€11.04
2017-Q1	Buy	1.5M	1.9M	+351K	€6.52–€10.68
2016-Q4	Buy	560K	1.5M	+948K
2016-Q3	Buy	311K	560K	+249K
2016-Q2	Buy	191K	311K	+119K
2016-Q1	Sell	460K	191K	-269K
2015-Q4	Buy	452K	460K	+8.2K
2015-Q3	Sell	502K	452K	-49K
2015-Q2	Buy	55K	502K	+446K

Transactions may be incomplete if the investor has purchased shares of the company before they reached the threshold for reporting set in the Securites Exchange Act or other applicable laws.

← Back to all investors